Illumina Inc (ILMN)

$99.25 -0.80 (-0.80%)
Market Cap 15.71B
Revenue (ttm) 4.37B
Net Income (ttm) -1.22B
EPS (ttm) N/A
PE Ratio 30.05
Forward PE 23.62
Profit Margin -27.97%
Debt to Equity Ratio 0.63
Volume 1,998,700
Avg Vol 2,290,862
Day's Range N/A - N/A
Shares Out 158.30M
Stochastic %K 64%
Beta 1.36
Analysts Sell
Price Target $105.87

Company Profile

Illumina, Inc. provides sequencing- and array-based solutions for genetic and genomic analysis in the Americas, Europe, Greater China, the Asia Pacific, the Middle East, and Africa. The company offers sequencing- and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other g...

Industry: Diagnostics & Research
Sector: Healthcare
Phone: 858 202 4500
Fax: 858 202 4545
Address:
5200 Illumina Way, San Diego, United States
harmongreg
harmongreg Jul. 13 at 4:19 PM
Dragonfly Capital - 5 Trade Ideas for Monday: AMD, CBOE, Capital One, Illumina and Microsoft $AMD $CBOE $COF $ILMN $MSFT https://dragonflycap.com/5-trade-ideas-for-monday-amd-cboe-capital-one-illumina-and-microsoft/
1 · Reply
JarvisFlow
JarvisFlow Jul. 11 at 12:30 PM
Scotiabank updates rating for Illumina ( $ILMN ) to Sector Perform, target set at 125.
0 · Reply
mstan
mstan Jul. 10 at 3:17 PM
$ILMN Citi group got this wrong https://finance.yahoo.com/news/illumina-named-times-worlds-most-131500742.html
0 · Reply
FreshBeckFresh
FreshBeckFresh Jul. 9 at 10:59 AM
$ILMN LOL these Analysts one Outperform and the other Sell... hilarious
1 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 10:30 AM
Citigroup has adjusted their stance on Illumina ( $ILMN ), setting the rating to Sell with a target price of 85 → 80.
0 · Reply
TopazFrenzy
TopazFrenzy Jul. 9 at 10:25 AM
$ILMN Citi downgraded Illumina (ILMN) to Sell from Neutral with a price target of $80, down from $85. The firm sees “significant” risk to estimates in the second half of 2025 and 2026 for Illumina. Citi cites funding uncertainty and increasing competitive risk for the downgrade to Sell. https://www.tipranks.com/news/the-fly/illumina-downgraded-to-sell-from-neutral-at-citi-thefly
1 · Reply
JarvisFlow
JarvisFlow Jul. 8 at 1:01 PM
Evercore ISI Group updates rating for Illumina ( $ILMN ) to Outperform, target set at 116 → 128.
0 · Reply
Sunny8393284923
Sunny8393284923 Jul. 3 at 6:21 PM
$ILMN potential 10x stock long term bigly bullish
0 · Reply
NwordFslur
NwordFslur Jul. 3 at 3:18 AM
$ILMN Whale here with 17 shares
0 · Reply
TegridyStocks
TegridyStocks Jul. 3 at 12:02 AM
$ILMN
0 · Reply
Latest News on ILMN
Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds

Jul 12, 2025, 3:46 AM EDT - 1 day ago

Illumina: Higher Profit Margin Despite GRAIL Divestiture And Macroeconomic Headwinds

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Jul 10, 2025, 4:05 PM EDT - 2 days ago

Illumina to Announce Second Quarter 2025 Financial Results on Thursday, July 31, 2025

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

Jul 10, 2025, 9:15 AM EDT - 3 days ago

Illumina named to TIME's World's Most Sustainable Companies list for the second consecutive year

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

Jun 23, 2025, 7:13 AM EDT - 20 days ago

Illumina to acquire SomaLogic, accelerating its proteomics business and advancing the company's multiomics strategy

LAB

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

Jun 18, 2025, 9:00 AM EDT - 25 days ago

Infinity Bio Closes $8M Series A Financing Led by Illumina Ventures to Expand Leadership in Antibody Reactome Profiling

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Jun 10, 2025, 4:01 PM EDT - 4 weeks ago

lllumina releases 2024 Corporate Social Responsibility Report as it advances its vision to unlock the power of genomics

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

May 29, 2025, 2:01 PM EDT - 6 weeks ago

Illumina unveils PromoterAI, a groundbreaking algorithm to accelerate insights for rare disease diagnosis

Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

May 29, 2025, 12:18 AM EDT - 6 weeks ago

Illumina, Inc. (ILMN) Bernstein 41st Annual Strategic Decisions Conference (Transcript)

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

May 28, 2025, 12:22 PM EDT - 6 weeks ago

Jefferies' Michael Yee: Drug discovery could be one of the biggest beneficiaries of generative AI

AMGN BIIB DHR GILD IBB NVS SDGR

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

May 28, 2025, 9:15 AM EDT - 6 weeks ago

Illumina expands clinical oncology portfolio unlocking new standard of care and access to precision therapies

Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry's Largest NGS-Based Proteomics Panel

May 19, 2025, 11:47 AM EDT - 7 weeks ago

Signios Bio and Illumina Announce Grant to Maximize Discovery Power with Industry's Largest NGS-Based Proteomics Panel

Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%

May 16, 2025, 11:28 AM EDT - 2 months ago

Icahn Ramps Up Bets On Genes And Jets: Illumina Stake Jumps 450%, JetBlue Holding Grow 90%

JBLU

Illumina To Webcast Upcoming Investor Conference

May 14, 2025, 4:05 PM EDT - 2 months ago

Illumina To Webcast Upcoming Investor Conference

Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications

May 13, 2025, 9:15 AM EDT - 2 months ago

Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications

Illumina Analysts Lower Their Forecasts After Q1 Results

May 12, 2025, 11:28 AM EDT - 2 months ago

Illumina Analysts Lower Their Forecasts After Q1 Results

Illumina: Multiple Headwinds Point To Limited Upside In 2025

May 10, 2025, 10:58 PM EDT - 2 months ago

Illumina: Multiple Headwinds Point To Limited Upside In 2025

Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript

May 8, 2025, 9:01 PM EDT - 2 months ago

Illumina, Inc. (ILMN) Q1 2025 Earnings Call Transcript

Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development

May 1, 2025, 9:15 AM EDT - 2 months ago

Illumina and Ovation.io launching first-of-kind GLP-1 dataset to accelerate new therapy development

Target Validation for Genetic Targets Innovation Research Report 2025: 14,172 Deals Totaling $11.4 Billion - BGI biotech and illumina are Among the Leaders with Strong Portfolios

Apr 18, 2025, 10:25 AM EDT - 3 months ago

Target Validation for Genetic Targets Innovation Research Report 2025: 14,172 Deals Totaling $11.4 Billion - BGI biotech and illumina are Among the Leaders with Strong Portfolios

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

Apr 15, 2025, 9:15 AM EDT - 3 months ago

Illumina and Tempus partner to drive the future of precision medicine through genomic AI innovation

TEM

Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025

Apr 10, 2025, 4:05 PM EDT - 3 months ago

Illumina to Announce First Quarter 2025 Financial Results on Thursday, May 8, 2025

Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholders

Mar 29, 2025, 7:25 AM EDT - 3 months ago

Corvex's Meister joins the board at Illumina. Here's how he can create value for shareholders

Is Illumina Undervalued After An 83% Drop In Its Stock Price?

Mar 27, 2025, 8:35 AM EDT - 3 months ago

Is Illumina Undervalued After An 83% Drop In Its Stock Price?

Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors

Mar 25, 2025, 9:00 AM EDT - 3 months ago

Illumina Board of Directors elects Dr. Scott Gottlieb Chair, Keith Meister to join Board of Directors

Activist investor Keith Meister to join Illumina's board, WSJ reports

Mar 25, 2025, 8:18 AM EDT - 3 months ago

Activist investor Keith Meister to join Illumina's board, WSJ reports

Activist Investor Meister to Join Illumina's Board

Mar 25, 2025, 8:00 AM EDT - 3 months ago

Activist Investor Meister to Join Illumina's Board

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

Mar 19, 2025, 9:15 AM EDT - 4 months ago

Alliance for Genomic Discovery completes 250,000 whole genomes to accelerate drug discovery

Illumina lowers outlook due to China sales ban, to cut $100 million in costs

Mar 10, 2025, 4:22 PM EDT - 4 months ago

Illumina lowers outlook due to China sales ban, to cut $100 million in costs

Illumina addresses recent developments in China

Mar 10, 2025, 4:10 PM EDT - 4 months ago

Illumina addresses recent developments in China

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban

Mar 10, 2025, 4:01 PM EDT - 4 months ago

Illumina to Cut $100 Million in Costs, Lowers Guidance Because of China Sales Ban

Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year

Mar 6, 2025, 9:15 AM EST - 4 months ago

Illumina named to Dow Jones Best-in-Class Indices for sixth consecutive year and as a Sustainability Yearbook Member for fourth consecutive year

US Firm Illumina Faces Setback as China Blocks Imports Amid Escalating Trade War

Mar 4, 2025, 9:57 AM EST - 4 months ago

US Firm Illumina Faces Setback as China Blocks Imports Amid Escalating Trade War

Illumina Stock Drops as China Bans Imports of Gene-Sequencing Technology

Mar 4, 2025, 9:38 AM EST - 4 months ago

Illumina Stock Drops as China Bans Imports of Gene-Sequencing Technology

China bans imports of Illumina's gene sequencers

Mar 4, 2025, 12:57 AM EST - 4 months ago

China bans imports of Illumina's gene sequencers

Illumina, Inc. (ILMN) AGBT Investor Session Conference (Transcript)

Feb 25, 2025, 7:43 PM EST - 4 months ago

Illumina, Inc. (ILMN) AGBT Investor Session Conference (Transcript)

Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology

Feb 24, 2025, 9:15 AM EST - 4 months ago

Illumina transforms multiomic research with new technologies to unlock deeper understanding of biology

Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions

Feb 21, 2025, 9:15 AM EST - 5 months ago

Illumina and Broad Clinical Labs usher in new era of drug discovery with collaboration to rapidly scale single-cell solutions

Illumina unveils first-of-its-kind spatial transcriptomics technology

Feb 19, 2025, 9:15 AM EST - 5 months ago

Illumina unveils first-of-its-kind spatial transcriptomics technology

Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference

Feb 18, 2025, 4:05 PM EST - 5 months ago

Illumina To Webcast Upcoming Investor Session at the Advances in Genome Biology and Technology (AGBT) Conference

Trump's Cuts to Medical Research Are Hurting These Stocks

Feb 12, 2025, 7:19 PM EST - 5 months ago

Trump's Cuts to Medical Research Are Hurting These Stocks

PACB TXG

Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability

Feb 10, 2025, 7:17 AM EST - 5 months ago

Illumina: Regulatory Risk In China And Weaker Sales Rebound Mask A Solid Rebound Of Its Profitability

Illumina Analysts Slash Their Forecasts Following Q4 Results

Feb 7, 2025, 2:22 PM EST - 5 months ago

Illumina Analysts Slash Their Forecasts Following Q4 Results

Illumina, Inc. (ILMN) Q4 2024 Earnings Call Transcript

Feb 6, 2025, 9:33 PM EST - 5 months ago

Illumina, Inc. (ILMN) Q4 2024 Earnings Call Transcript

Illumina forecasts 2025 revenue largely below estimates

Feb 6, 2025, 4:42 PM EST - 5 months ago

Illumina forecasts 2025 revenue largely below estimates

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024

Feb 6, 2025, 4:05 PM EST - 5 months ago

Illumina Reports Financial Results for Fourth Quarter and Fiscal Year 2024

China hits back at Trump's tariffs, targeting select U.S. imports

Feb 4, 2025, 11:48 AM EST - 5 months ago

China hits back at Trump's tariffs, targeting select U.S. imports

GOOG GOOGL PVH

Calvin Klein Parent PVH, Illumina Put on China's 'Unreliable Entity' List

Feb 4, 2025, 11:36 AM EST - 5 months ago

Calvin Klein Parent PVH, Illumina Put on China's 'Unreliable Entity' List

PVH

China retaliates against US with tariffs, antitrust probes

Feb 4, 2025, 11:26 AM EST - 5 months ago

China retaliates against US with tariffs, antitrust probes

GOOG GOOGL PVH

China retaliates with additional tariffs of up to 15% on select U.S. imports

Feb 4, 2025, 11:15 AM EST - 5 months ago

China retaliates with additional tariffs of up to 15% on select U.S. imports

GOOG GOOGL PVH

China puts PVH Corp, Illumina on its unreliable entity list

Feb 4, 2025, 12:57 AM EST - 5 months ago

China puts PVH Corp, Illumina on its unreliable entity list

PVH

harmongreg
harmongreg Jul. 13 at 4:19 PM
Dragonfly Capital - 5 Trade Ideas for Monday: AMD, CBOE, Capital One, Illumina and Microsoft $AMD $CBOE $COF $ILMN $MSFT https://dragonflycap.com/5-trade-ideas-for-monday-amd-cboe-capital-one-illumina-and-microsoft/
1 · Reply
JarvisFlow
JarvisFlow Jul. 11 at 12:30 PM
Scotiabank updates rating for Illumina ( $ILMN ) to Sector Perform, target set at 125.
0 · Reply
mstan
mstan Jul. 10 at 3:17 PM
$ILMN Citi group got this wrong https://finance.yahoo.com/news/illumina-named-times-worlds-most-131500742.html
0 · Reply
FreshBeckFresh
FreshBeckFresh Jul. 9 at 10:59 AM
$ILMN LOL these Analysts one Outperform and the other Sell... hilarious
1 · Reply
JarvisFlow
JarvisFlow Jul. 9 at 10:30 AM
Citigroup has adjusted their stance on Illumina ( $ILMN ), setting the rating to Sell with a target price of 85 → 80.
0 · Reply
TopazFrenzy
TopazFrenzy Jul. 9 at 10:25 AM
$ILMN Citi downgraded Illumina (ILMN) to Sell from Neutral with a price target of $80, down from $85. The firm sees “significant” risk to estimates in the second half of 2025 and 2026 for Illumina. Citi cites funding uncertainty and increasing competitive risk for the downgrade to Sell. https://www.tipranks.com/news/the-fly/illumina-downgraded-to-sell-from-neutral-at-citi-thefly
1 · Reply
JarvisFlow
JarvisFlow Jul. 8 at 1:01 PM
Evercore ISI Group updates rating for Illumina ( $ILMN ) to Outperform, target set at 116 → 128.
0 · Reply
Sunny8393284923
Sunny8393284923 Jul. 3 at 6:21 PM
$ILMN potential 10x stock long term bigly bullish
0 · Reply
NwordFslur
NwordFslur Jul. 3 at 3:18 AM
$ILMN Whale here with 17 shares
0 · Reply
TegridyStocks
TegridyStocks Jul. 3 at 12:02 AM
$ILMN
0 · Reply
Mbs7bro
Mbs7bro Jul. 2 at 5:19 PM
$QSI Last dot connected with influx of insider buying including CEO! Just wait for AI assistance to accelerate this and we wont have to wait 20+ years like $ILMN who focused on DNA 🧬!
0 · Reply
mstan
mstan Jun. 30 at 7:29 PM
$ILMN nice strong uptrend breaking into even stronger uptrend but I won't get get excited until we break 150 $ resistance. GL longs is long journey but IMO will get to ATH in 2-3 years.
0 · Reply
iTrade_Price
iTrade_Price Jun. 29 at 11:44 PM
$ILMN ilmn -- will get back in for a bounce
0 · Reply
whowantstobeamillionaire
whowantstobeamillionaire Jun. 29 at 8:19 AM
$ILMN this one is going parabolic. $150-160 coming next…
0 · Reply
peakbuying
peakbuying Jun. 28 at 6:48 AM
$ILMN The next big sector once the robotics / nuclear hype dies off
1 · Reply
goldilucks
goldilucks Jun. 27 at 5:29 PM
$ILMN When the unstated goal of your company is to undo all pretenses of growth the ground is the limit
0 · Reply
TwoToesTrading
TwoToesTrading Jun. 26 at 3:42 PM
$DDOG $ILMN $MBLY $RUN $TSSI more Flow
0 · Reply
LittleJohn213
LittleJohn213 Jun. 26 at 2:24 PM
$ILMN LFG!
0 · Reply
ZacksResearch
ZacksResearch Jun. 26 at 1:37 PM
$ILMN's strategic acquisition: game-changer for proteomics? 🎯 🌟 $350M deal for SomaLogic to boost Illumina’s multiomics strategy 📈 Shares up 2.9% since June 23, positive market sentiment expected 🔬 Illumina expects SomaLogic's business to become profitable in 2027 and margins align in 2028 Discover the full impact here 👉 https://www.zacks.com/commentary/2554296/illumina-stock-may-benefit-from-new-agreement-to-acquire-somalogic?cid=sm-stocktwits-2-2554296-body-173&ADID=SYND_STOCKTWITS_TWEET_2_2554296_BODY_173
0 · Reply
ZacksResearch
ZacksResearch Jun. 26 at 11:08 AM
$ILMN just made a bold move — here’s why it could pay off 💥 Shares jumped 2.9% after announcing a $350M deal to acquire SomaLogic, strengthening its multiomics growth push. See what this means for the future of ILMN’s strategy 👉 https://www.zacks.com/stock/news/2554296/illumina-stock-may-benefit-from-new-agreement-to-acquire-somalogic?cid=sm-stocktwits-2-2554296-teaser&ADID=SYND_STOCKTWITS_TWEET_2_2554296_TEASER
0 · Reply
DonCorleone77
DonCorleone77 Jun. 25 at 10:07 PM
$ILMN $TMO $AVTR NIH directs staff not to end any extra research projects for now, NY Times says A senior official the National Institutes of Health has told agency staff not to cancel any more research projects for the time being in the wake of two court rulings taking umbrage with the cancellation of medical research grants by the Trump administration, the New York Times' Benjamin Mueller reports, citing an internal memo. The directive marks a retreat by the agency, as it has slashed funding for medical research since Trump's return to office by terminating hundreds of awards, the author notes. Shares of Illumina (ILMN), Thermo Fisher (TMO), Avantor (AVTR), and Bruker (BRKR) moved higher following the news, while Icon (ICLR) and Medpace (MEDP) were still in the red but curtailed some earlier losses.
0 · Reply
tarzzanman
tarzzanman Jun. 25 at 8:41 PM
$ILMN Will it finally break out back to +120$?
1 · Reply